Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis

Leukemia

Volumn 15, Issue 6, 2001, Pages 976-980

  Di Raimondo, F ^a   Azzaro, M P ^a   Palumbo, G A ^a   Bagnato, S ^a   Stagno, F ^a   Giustolisi, G M ^a   Cacciola, E ^a   Sortino, G ^a   Guglielmo, P ^a   Giustolisi, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Myelofibrosis; Platelets; VEGF

Indexed keywords

ANGIOGENIC FACTOR; CREATININE; HEMOGLOBIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CALCULATION; CIRCULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSITY; EVALUATION; FEMALE; FIBROSIS; HUMAN; LABORATORY TEST; LEUKOCYTE; MALE; MICROVASCULATURE; MYELOFIBROSIS; MYELOID METAPLASIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SPLENOMEGALY; THERAPY; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA;

EID: 0034983733     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402124     Document Type: Article

References (34)

1. Biology of vascular endothelial growth factor
2. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
3. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (P1GF) in regulating human haemopoietic cell growth
4. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
5. Tumor vascularity as a prognostic factor in cancer
6. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
7. Quantification of angiogenesis in solid human tumors: An international consensus on the methodology and criteria of evaluation
8. Mechanisms of angiogenesis
9. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vitro
10. Elevated levels of the angiogenic cytokines basic fibroblastic growth factor and vascular endothelia growth factor in sera of cancer patients
11. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
12. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
13. Plasma levels of VEGF and bFGF in various leukemias and their correlation with angiogenesis
14. Vascular endothelial growth factor (VEGF) is an autocrine promoter of ALIP and leukemia progenitor formation in myelodysplastic syndromes (MDS)
15. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma
16. Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: An immunomorphometric study on trephine biopsies of the bone marrow
17. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity
18. Myelofibrosis with myeloid metaplasia
19. Evaluation and clinical correlations of microvessel density in myelofibrosis with myeloid metaplasia
20. Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: Evidence for a role of extracellular calodulin in fibroblast proliferation
21. Differential expression of transforming growth factor-β, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia
22. Elevated levels of basic fibroblast growth factor in megakaryocyts and platelets from patients with idiopathic myeofibrosis
23. Leukocyte and platelets of patients with cancer contain high levels of vascular endothelial growth factor
24. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?
25. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
26. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
27. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
28. Platelet: Transporter of vascular endothelial growth factor
29. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effet of VEGF on apoptotic cell death caused by ionizing radiation
30. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
31. Thrombin induces vascular endothelial cell growth factor (VEGF) in human tumor cells and fibroblasts
32. KDR receptor: A key marker defining hematopoietic stem cells
33. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines
34. Thalidomide anti-angiogenesis therapy (RX) in Philadelphia (Ph)-negative myeloproliferative disorders (MPD) and myelofibrosis (MF)